The National Health Surveillance Agency (Anvisa) approved this Monday (21) the sale of Paxlovid, a drug for the treatment of Covid-19, in pharmacies. Purchases can only be made with a prescription.
Thus, the supply of the drug to the private market is authorised, with the labeling and leaflet in Portuguese from Portugal and in Spanish. The Agency highlighted, however, that the manufacturer must maintain and prioritize the supply of the Unified Health System (SUS).
The approval took place unanimously by the collegiate board of the body, which also confirmed the extension of the validity of the medicine from 12 months to 18 months.
“The approval took into account the sale of the medicine to the private market in other countries with reference international authorities, such as the United States and Canada. The measure also considered the current epidemiological scenario, with the circulation of new subvariants of Ômicron and the increase in cases of the disease in the country”, explains the note from Anvisa.
The medicine must be taken within five days of symptoms. The director and rapporteur of the piece, Meiruze Freitas, stressed, however, that the medicine does not replace vaccination, which “remains the best strategy to avoid Covid-19, hospitalizations and deaths”.
*in update
Source: CNN Brasil
I am an experienced journalist and writer with a career in the news industry. My focus is on covering Top News stories for World Stock Market, where I provide comprehensive analysis and commentary on markets around the world. I have expertise in writing both long-form articles and shorter pieces that deliver timely, relevant updates to readers.
